Docetaxel
Sagent Voluntarily Recalls Lots of Docetaxel Injection
On May 28, Sagent Pharmaceuticals announced the recall of two lots of docetaxel injection, USP (80 mg per 8 mL and ...
JUNE 7, 2024
Continuing Enzalutamide After Progression and Adding Docetaxel Improved PFS in mCRPC, Study Shows
Adding docetaxel and prednisolone after progression on enzalutamide (Xtandi, Astellas) alone significantly extended ...
MARCH 25, 2022
New Agent Increases Efficacy, Improves Safety of Docetaxel
An experimental agent, plinabulin (NPI-2358, BeyondSpring Pharmaceuticals), may increase the efficacy and safety of ...
MARCH 9, 2017
Low-Dose Capecitabine Plus Docetaxel Offers Better PFS Than Docetaxel Alone
Low-dose capecitabine plus docetaxel demonstrated slightly better progression-free survival compared with ...
FEBRUARY 2, 2017
Veristrat Does Not Predict Difference in PFS for Erlotinib Versus Docetaxel
A blood-based proteomic test could not predict if erlotinib or docetaxel would result in better survival outcomes ...
JANUARY 25, 2017
Neo Adjuvant Docetaxel + Cyclophosphamide Shows Low pCR Rate in HER2-Negative Patients
A neoadjuvant chemotherapy regimen of docetaxel plus cyclophosphamide was well tolerated but yielded a low ...
JANUARY 17, 2017
Progression With Docetaxel After Prostatectomy
Chicago—Docetaxel monotherapy after radical prostatectomy was associated with more-rapid biochemical ...
AUGUST 11, 2016
